Skip to main content
. 2022 Sep 2;13:926984. doi: 10.3389/fgene.2022.926984

FIGURE 5.

FIGURE 5

Identification of the efficiency of GILncRNASig in clinical characteristics. (A). Comparison of the time-dependent ROC curve with other characteristic-related lncRNAs model. (B). Kaplan–Meier curves of overall survival of patients between low- and high-risk groups in patients with Age <65 and Age ≥65. (C). Kaplan–Meier curves of overall survival of patients between low- and high-risk groups in patients with Stage I–II and Stage III–IV.